Close

Nektar Therapeutics (NKTR) Tops Q4 EPS by 3c

Go back to Nektar Therapeutics (NKTR) Tops Q4 EPS by 3c

Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results

February 25, 2021 4:15 PM EST

SAN FRANCISCO, Feb. 25, 2021 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2020.

Cash and investments in marketable securities at December 31, 2020 were approximately $1.2 billion as compared to $1.6 billion at December 31, 2019.

"This past year,... More